121 related articles for article (PubMed ID: 22000981)
41. [Incidence of venous thromboembolism in men admitted to a pneumology unit for acute respiratory disease].
Aissa I; Rachdi I; Ben Miled K; Ghedira H
Rev Pneumol Clin; 2011 Jun; 67(3):129-35. PubMed ID: 21665075
[TBL] [Abstract][Full Text] [Related]
42. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
White RH; Chan WS; Zhou H; Ginsberg JS
Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
[TBL] [Abstract][Full Text] [Related]
43. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
[TBL] [Abstract][Full Text] [Related]
44. When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes.
Duska LR; Garrett L; Henretta M; Ferriss JS; Lee L; Horowitz N
Gynecol Oncol; 2010 Mar; 116(3):374-7. PubMed ID: 19922988
[TBL] [Abstract][Full Text] [Related]
45. A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system.
Yu YB; Gau JP; Liu CY; Yang MH; Chiang SC; Hsu HC; Hong YC; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Lee TS; Chou LF; Tzeng CH; Chen TJ
Thromb Haemost; 2012 Aug; 108(2):225-35. PubMed ID: 22534880
[TBL] [Abstract][Full Text] [Related]
46. [Analysis of prognostic risk factors in patients with diffuse large B-cell lymphoma].
Yu ZP; Ding JH; Chen BA; Gao C; Wang LL; Chen Z
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):830-5. PubMed ID: 22339956
[TBL] [Abstract][Full Text] [Related]
47. A novel scoring system for predicting postoperative venous thromboembolic complications in patients after open aortic surgery.
Scarborough JE; Cox MW; Mureebe L; Pappas TN; Shortell CK
J Am Coll Surg; 2012 Apr; 214(4):620-6; discussion 627-8. PubMed ID: 22342790
[TBL] [Abstract][Full Text] [Related]
48. Long-term prospective study of recurrent venous thromboembolism in a Hispanic population.
Mello TB; Orsi FL; Montalvao SA; Ozelo MC; de Paula EV; Annichinno-Bizzachi JM
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):660-5. PubMed ID: 20829682
[TBL] [Abstract][Full Text] [Related]
49. [Frequency of venous thromboembolism among hospitalized patients with cancer].
Conte G; Figueroa G
Rev Med Chil; 2008 Dec; 136(12):1528-34. PubMed ID: 19350169
[TBL] [Abstract][Full Text] [Related]
50. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
51. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.
Tai WM; Chung J; Tang PL; Koo YX; Hou X; Tay KW; Quek R; Tao M; Lim ST
Ann Hematol; 2011 Jul; 90(7):809-18. PubMed ID: 21229246
[TBL] [Abstract][Full Text] [Related]
52. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
Chew HK; Wun T; Harvey DJ; Zhou H; White RH
J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
[TBL] [Abstract][Full Text] [Related]
53. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
Wiseman DN; Harrison J
N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
[TBL] [Abstract][Full Text] [Related]
54. Venous thromboembolism in association with features of the metabolic syndrome.
Ray JG; Lonn E; Yi Q; Rathe A; Sheridan P; Kearon C; ; Yusuf S; Arnold MJ; McQueen MJ; Pogue J; Probstfield J; Fodor G; Held C; Micks M; Genest J
QJM; 2007 Nov; 100(11):679-84. PubMed ID: 17846056
[TBL] [Abstract][Full Text] [Related]
55. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group.
Li X; Liu Z; Cao J; Hong X; Wang J; Chen F; Wang C; Zou S; Li J; Shen Z
Ann Hematol; 2012 Jun; 91(6):837-45. PubMed ID: 22160255
[TBL] [Abstract][Full Text] [Related]
56. Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis.
Amin AN; Lin J; Lenhart G; Schulman KL
Thromb Haemost; 2009 Aug; 102(2):321-6. PubMed ID: 19652883
[TBL] [Abstract][Full Text] [Related]
57. Incidence of venous thromboembolism in patients undergoing surgical treatment for malignancy by type of neoplasm: An analysis of ACS-NSQIP data from 2005 to 2010.
Reinke CE; Karakousis GC; Hadler RA; Drebin JA; Fraker DL; Kelz RR
Surgery; 2012 Aug; 152(2):186-92. PubMed ID: 22828139
[TBL] [Abstract][Full Text] [Related]
58. Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival.
Abu Saadeh F; Norris L; O'Toole S; Gleeson N
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):214-8. PubMed ID: 23830352
[TBL] [Abstract][Full Text] [Related]
59. Incidence of venous thromboembolism in psychiatric units.
Delluc A; Montavon S; Canceil O; Carpentier M; Nowak E; Mercier B; Bressollette L; Etienne S; Walter M; Mottier D; Lacut K
Thromb Res; 2012 Dec; 130(6):e283-8. PubMed ID: 23092750
[TBL] [Abstract][Full Text] [Related]
60. The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma.
Abdel-Razeq H; Ma'koseh M; Mansour A; Bater R; Amarin R; Abufara A; Halahleh K; Manassra M; Alrwashdeh M; Almomani M; Zmaily M
Clin Appl Thromb Hemost; 2021; 27():10760296211045908. PubMed ID: 34590497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
